Medical Health & Life Science Research News

Global respiratory inhalers market to hit $33.57 billion by 2023

The global respiratory inhalers market is expected to reach USD 33,572.9 Million by 2023 at a CAGR of 6.1% during the forecast period. 

- Agency -.

Executive Summary:

Respiratory inhalers are the devices which are used to control the respiratory conditions by directly inhaling the drug into the respiratory tract. Respiratory inhalers are used to assist a patient encountering breathing problems resulting from respiratory disorders such as fibrosis, asthma, COPD and ARDS and others.  

Globally, on the basis of type, manually operated inhalers account for the largest market share of 89.9%, of the market in 2016.

- Agency -.

The massive share is majorly attributed to the widespread availability and use of the conventional inhaler devices and the lack of awareness and the lesser availability of the digital and smart inhaler devices in all parts of the world.

However, the market is changing and Digital inhalers & smart inhaler segment will show a rapid growth globally after 2018. 

Globally, On the basis of application, COPD will be the fastest growing application segment growing at a CAGR of 6.5% from 2017 to 2023, as the number of COPD patients is on the rise and patients need a concrete treatment method to counter the disease. Moreover, many awareness programs and campaigns have been started in the last few years in the developing regions such as Asia-Pacific and Middle East & Africa.  

Dry Powder Inhalers segment accounted for the largest market share of North America respiratory inhalers market, by product, registering revenue of USD 3,969.6 million in 2016 and expected to reach USD 6,421.0 million by 2023. In North America, metered dose inhalers is the fastest growing segment, and is expected to grow at the CAGR of 6.7% during forecasted period.

Dry Powder Inhaler segment being available widespread dominated the market in most of the countries such as US, Germany, France, UK, India, China, Australia, Middle East, and Republic of Korea among others. Apart from these two,

North America commands largest market share of 35.1%, minting USD 7,237.8 million in 2016. European market is second largest after North America with 33.3% market share.

Globally, Asia-Pacific region is one of the fastest growing markets for Respiratory Inhalers. It was valued at USD 4,628.5 million in 2016, and is expected to reach USD 7,841.3 million by 2023, at the rate of 6.7% during the forecast period.

Request Sample Report Here @ www.wiseguyreports.com/sample-requ…orecast-2014-2023                                              

...

Key Players

The leading market players in the global respiratory inhalers market include Adherium Limited, AstraZeneca PLC, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., GlaxoSmithKline PLC, Propeller Health, and Teva Pharmaceutical Industries Ltd. 

Study objectives of Respiratory Inhalers market

Ø    To provide insights about factors influencing and affecting the market growth

Ø    To provide historical and forecast revenues of the market segments and sub-segments with respect to regional and country-level markets

Ø    To provide historical and forecast revenue of the market segments based on types, products, applications, end users, and its sub-segments.

Ø    To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market 

Target Audience

  • Medical devices manufacturers
  • Medical devices distributors
  • Pharmaceutical companies
  • Hospitals & Clinics
  • Potential investors
  • Key executive (CEO and COO) and strategy growth manager 

Key Findings

  • Metered Dose Inhalers will be the fastest growing product segment growing at a CAGR of 6.5% from 2017 to 2023
  • COPD will be the fastest growing Application segment growing at a CAGR of 6.5% from 2017 to 2023
  • North America held the largest market share of 35.1% in 2016, while Asia-Pacific is expected to register fastest growth of 6.7% CAGR during the forecast period.
  • Asia-Pacific market is expected to reach by USD 7,841.3 million by 2023.

 The reports also cover country level analysis:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest Of Western Europe
  • Eastern Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Republic of Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Middle East
  • Africa

Enquire about report @ www.wiseguyreports.com/enquiry/141…orecast-2014-2023                                              

Some Major Points from Table of Content:           

Table of Contents

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope of Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

2.5 Market Structure

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

4 Market Dynamics

4.1 Introducton

4.2 Drivers

4.2.1 Rising prevalence of chronic respiratory disease

4.2.2 Increasing usage of combination therapy

4.2.3 Growing need for rescue medication

4.2.4 Technological advancements

4.3 Restraints

4.3.1 No single, effective device for every respiratory disorders

4.3.2 Side effects and complications during inhalation

4.3.3 High price

4.3.4 Non-standardized dosage

4.4 Opportunities

4.4.1 Advanced products

4.4.2 Increasing demand in developing countries

4.5 Challenges

4.5.1 Strong competition

4.5.2 More advanced products

5 Market Factor Analysis

5.1 Porter’s Five Forces Model

5.1.1 Bargaining power of suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

6 Global Respiratory Inhalers Market, By Type

6.1 Introduction

6.2 Manually Operated Inhaler

6.3 Digitally Operated Inhaler

7 Global Respiratory Inhalers Market, By Product

7.1 Introduction

7.2 Dry Powder Inhaler

7.3 Metered Dose Inhaler

8 Global Respiratory Inhalers Market, By Application

8.1 Introduction

8.2 Asthma

8.3 COPD

9 Global Respiratory Inhalers Market, By End User

9.1 Introduction

9.2 Hospitals & Clinics

9.3 Respiratory Care Centers

List of Tables and Figures

TABLE 1 GLOBAL RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 2 GLOBAL MANUALLY OPERATED INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)

TABLE 3 GLOBAL DIGITALLY OPERATED INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)

TABLE 4 GLOBAL RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 5 GLOBAL DRY POWDER INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)

TABLE 6 GLOBAL METERED DOSE INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)

TABLE 7 GLOBAL RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 8 GLOBAL RESPIRATORY INHALER MARKET FOR ASTHMA, BY REGION, 2014-2023 (USD MILLION)

TABLE 9 GLOBAL RESPIRATORY INHALER MARKET FOR COPD, BY REGION, 2014-2023 (USD MILLION)

TABLE 10 GLOBAL RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 11 GLOBAL RESPIRATORY MARKET FOR HOSPITAL, BY REGION, 2014-2023 (USD MILLION)

TABLE 12 GLOBAL RESPIRATORY INHALER MARKET FOR RESPIRATORY CARE CENTERS, BY REGION,

2014-2023 (USD MILLION) 39

TABLE 13 GLOBAL RESPIRATORY INHALERS MARKET, BY REGION, 2014-2023 (USD MILLION)

TABLE 14 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY COUNTRY, 2014-2023 (USD MILLION)

TABLE 15 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 16 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 17 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 18 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 19 US RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 20 US RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 21 US RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 22 US RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 23 CANADA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 24 CANADA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 25 CANADA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 26 CANADA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 27 EUROPE RESPIRATORY INHALERS MARKET, BY COUNTRY, 2014-2023 (USD MILLION)

TABLE 28 EUROPE RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

……CONTINUED

News From

Wise Guy Reports - Market ResearchWise Guy Reports
Category: Market Research Publishers and RetailersCompany profile: Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs. Our Market Research Reports and Consulting Services  ...